Results 241 to 250 of about 14,437,638 (295)
Some of the next articles are maybe not open access.
Journal of the European Academy of Dermatology and Venereology, 2003
ABSTRACTCutaneous T‐cell lymphoma (CTCL) is a neoplasm of helper T cells whose first manifestations usually appear in the skin. The various forms of CTCL are distinguished by both clinical features and histopathology. Early on, the diagnosis may be difficult to establish because of its numerous, and often non‐specific, clinical presentations.
E A, Kotz, D, Anderson, B H, Thiers
openaire +2 more sources
ABSTRACTCutaneous T‐cell lymphoma (CTCL) is a neoplasm of helper T cells whose first manifestations usually appear in the skin. The various forms of CTCL are distinguished by both clinical features and histopathology. Early on, the diagnosis may be difficult to establish because of its numerous, and often non‐specific, clinical presentations.
E A, Kotz, D, Anderson, B H, Thiers
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2008
Cutaneous T-cell lymphoma comprises a heterogeneous group of lymphoproliferative disorders characterized by clonal expansions of mature, post-thymic T cells that infiltrate the skin. This article discusses the staging, prognosis, and treatment of mycosis fungoides and Sézary syndrome.
Frederick, Lansigan +2 more
openaire +2 more sources
Cutaneous T-cell lymphoma comprises a heterogeneous group of lymphoproliferative disorders characterized by clonal expansions of mature, post-thymic T cells that infiltrate the skin. This article discusses the staging, prognosis, and treatment of mycosis fungoides and Sézary syndrome.
Frederick, Lansigan +2 more
openaire +2 more sources
Medical Clinics of North America, 1982
Cutaneous T cell lymphoma is a malignancy of helper T cells, which have a propensity to infiltrate the skin. The incidence of the disease appears to exceed that of Hodgkin's disease, making it the most common lymphoma of adults. Advances in our knowledge of the biology of the malignant T cells should facilitate new and more effective forms of treatment.
J A, Patterson, R L, Edelson
openaire +2 more sources
Cutaneous T cell lymphoma is a malignancy of helper T cells, which have a propensity to infiltrate the skin. The incidence of the disease appears to exceed that of Hodgkin's disease, making it the most common lymphoma of adults. Advances in our knowledge of the biology of the malignant T cells should facilitate new and more effective forms of treatment.
J A, Patterson, R L, Edelson
openaire +2 more sources
Journal of the American Academy of Dermatology, 2004
Cutaneous T-cell lymphomas arise in the skin and are classified by their clinical presentation and cell surface markers. Mycosis fungoides and the Sezary syndrome are the most frequently encountered, followed by the CD30+ lymphoproliferative disorders.
Madeleine, Duvic, Richard, Edelson
openaire +2 more sources
Cutaneous T-cell lymphomas arise in the skin and are classified by their clinical presentation and cell surface markers. Mycosis fungoides and the Sezary syndrome are the most frequently encountered, followed by the CD30+ lymphoproliferative disorders.
Madeleine, Duvic, Richard, Edelson
openaire +2 more sources
Current Opinion in Oncology, 1993
Cutaneous T-cell lymphoma, which usually presents as mycosis fungoides or Sézary syndrome, remains a mostly incurable, yet highly treatable group of diseases. The myriad of active therapies continues to grow, and new insights into the mechanism of systemic and topical therapies are being elucidated.
E H, Kaplan, W T, Leslie
openaire +2 more sources
Cutaneous T-cell lymphoma, which usually presents as mycosis fungoides or Sézary syndrome, remains a mostly incurable, yet highly treatable group of diseases. The myriad of active therapies continues to grow, and new insights into the mechanism of systemic and topical therapies are being elucidated.
E H, Kaplan, W T, Leslie
openaire +2 more sources
The Journal of Dermatology, 1980
AbstractCutaneous T cell lymphoma (CTCL) is a generic classification of clonally‐derived malignancies of phenotypic helper/inducer T cells with a propensity to infiltrate the skin, migrate into the epidermis, localize in T cell zones of lymphoid structures and spare the bone marrow.
openaire +3 more sources
AbstractCutaneous T cell lymphoma (CTCL) is a generic classification of clonally‐derived malignancies of phenotypic helper/inducer T cells with a propensity to infiltrate the skin, migrate into the epidermis, localize in T cell zones of lymphoid structures and spare the bone marrow.
openaire +3 more sources
Seminars in Oncology Nursing, 1998
To describe the current state of the knowledge regarding the pathology, clinical presentation, treatment strategies, and nursing management of patients with cutaneous T-cell lymphoma, specifically, mycosis fungoides and the Sezary syndrome.Book chapters, review articles, published research studies, proceedings from professional meetings.Although ...
openaire +2 more sources
To describe the current state of the knowledge regarding the pathology, clinical presentation, treatment strategies, and nursing management of patients with cutaneous T-cell lymphoma, specifically, mycosis fungoides and the Sezary syndrome.Book chapters, review articles, published research studies, proceedings from professional meetings.Although ...
openaire +2 more sources
Medical Clinics of North America, 1986
Cutaneous T cell lymphoma is a malignancy of helper T cells, which have a propensity to infiltrate the skin. The incidence of the disease appears to exceed that of Hodgkin's disease, making it the most common lymphoma of adults. Advances in our knowledge of the biology of the malignant T cells should facilitate new and more effective forms of treatment.
R M, Knobler, R L, Edelson
openaire +2 more sources
Cutaneous T cell lymphoma is a malignancy of helper T cells, which have a propensity to infiltrate the skin. The incidence of the disease appears to exceed that of Hodgkin's disease, making it the most common lymphoma of adults. Advances in our knowledge of the biology of the malignant T cells should facilitate new and more effective forms of treatment.
R M, Knobler, R L, Edelson
openaire +2 more sources
Treatment of cutaneous T-cell lymphomas
Seminars in Cutaneous Medicine and Surgery, 2000Primary cutaneous T-cell lymphomas (CTCL), representing a heterogeneous group of non-Hodgkin's lymphomas (NHL), can be defined as clonal proliferation of skin-infiltrating T lymphocytes primarily presenting in the cutaneous compartment. They show a considerable variation in clinical presentation, histology, immunophenotype, and prognosis, which is best
J M, Muche, S, Gellrich, W, Sterry
openaire +2 more sources
Seminars in Oncology Nursing, 1991
I N 1806, FRENCH dermatologist Baron Jean Louis Alibert’ identified the unique characteristics of the disease process known today as cutaneous T-cell lymphoma (CTCL). He called it “mycosis fungoides” (MF), not because it was a fungus, but because of the mushroom-like nature of the cutaneous lesions found in the advanced stages of the disease.
openaire +2 more sources
I N 1806, FRENCH dermatologist Baron Jean Louis Alibert’ identified the unique characteristics of the disease process known today as cutaneous T-cell lymphoma (CTCL). He called it “mycosis fungoides” (MF), not because it was a fungus, but because of the mushroom-like nature of the cutaneous lesions found in the advanced stages of the disease.
openaire +2 more sources